Page last updated: 2024-09-04

febuxostat and Koch's Disease

febuxostat has been researched along with Koch's Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Kang, SM; Kim, LH; Kwon, KW; Shin, SJ; Whang, J1

Other Studies

1 other study(ies) available for febuxostat and Koch's Disease

ArticleYear
Novel Antibacterial Activity of Febuxostat, an FDA-Approved Antigout Drug against Mycobacterium tuberculosis Infection.
    Antimicrobial agents and chemotherapy, 2022, 09-20, Volume: 66, Issue:9

    Topics: Allopurinol; Animals; Antitubercular Agents; Febuxostat; Mice; Mycobacterium tuberculosis; Tuberculosis

2022